liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Persistence to antihypertensive drug classes in uncomplicated hypertension: a nationwide Swedish cohort study
Uppsala Univ, Sweden.
Uppsala Univ, Sweden.
Uppsala Univ, Sweden.
Uppsala Univ, Sweden.
Show others and affiliations
2026 (English)In: eClinicalMedicine, E-ISSN 2589-5370, Vol. 91, article id 103696Article in journal (Refereed) Published
Abstract [en]

Background Only half of patients appear adherent to antihypertensive treatment. If so, the effectiveness in prevention against adverse cardiovascular outcomes may depend more on a drugs' side effects than its blood pressure effects. We hypothesized that initiating treatment with a particular antihypertensive drug class will determine later persistence. Methods We applied a new-user trial emulation approach to multiple mandatory health-care registers in Sweden. All individuals starting antihypertensive treatment with an angiotensin receptor blocker (ARB), angiotensin converting enzyme inhibitor (ACEi), calcium channel blocker (CCB), thiazide/thiazide-like diuretic (TD), or single-pill combination of two drugs (SPC) in 2011-2018 were assessed for inclusion. Patients with prior cardiovascular disease or diabetes were excluded. Persistence was defined using dispensed prescription refills with at least 80% adherence. We applied multistate Poisson regression models adjusting for age, sex, obesity, birth country, education, income, marital status and year of initiation. The study period was January 1st 2011-December 31st 2019. Findings A total of 341,182 patients were included. Initiating antihypertensive treatment with an ARB was associated with a larger proportion continuing their original drug class, or indeed any antihypertensive drug class, at any time during the five years of follow-up. At three years, 44.7% (CI 43.7-45.7) of the ARB initiators were continuously persistent to their original drug class. The corresponding number if intermittent discontinuations were allowed was 81.8% (CI 80.9-82.8). Overall, if intermittent discontinuations and changes between classes were allowed, about 80% of all new users of antihypertensive drugs (regardless of class at initiation) were persistent to at least one antihypertensive drug class over 5 years. Interpretation Initiating treatment with an ARB is associated with the best long-term class persistence and least treatment changes. The "rule of halves" should be replaced with the insight that, after the first year, at least 4 out of 5 patients take their antihypertensive drug at least 4 out of 5 days. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Place, publisher, year, edition, pages
ELSEVIER , 2026. Vol. 91, article id 103696
Keywords [en]
Persistence; Medication adherence; Antihypertensive agents; Register study; Hypertension; First-line; drug choice
National Category
Social and Clinical Pharmacy
Identifiers
URN: urn:nbn:se:liu:diva-221135DOI: 10.1016/j.eclinm.2025.103696ISI: 001677277600001PubMedID: 41625962OAI: oai:DiVA.org:liu-221135DiVA, id: diva2:2037330
Note

Funding Agencies|Geriatric Foundation, Uppsala Sweden; Swedish Research Council [sens2020005, sens2020598, 2018-05973]

Available from: 2026-02-10 Created: 2026-02-10 Last updated: 2026-03-31

Open Access in DiVA

fulltext(2738 kB)17 downloads
File information
File name FULLTEXT01.pdfFile size 2738 kBChecksum SHA-512
e71af45fcf960da2bf2e9b8d1b3397a6a84b91cde20e38f64bbb7f1e3e7b9861a5e8f73cccb9016e725767f1c395b2a074a0eae2ef5900749cc0850e3b916bc3
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Rådholm, Karin
By organisation
Division of Prevention, Rehabilitation and Community MedicineFaculty of Medicine and Health SciencesPrimary Health Care Center Kärna
In the same journal
eClinicalMedicine
Social and Clinical Pharmacy

Search outside of DiVA

GoogleGoogle Scholar
Total: 17 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 42 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf